For laboratory research use only — not for human consumption

Legality4 min read

Is MOTS-c Legal in Australia? A Research Perspective

How the mitochondrial-derived peptide MOTS-c sits under Australian regulation as a research compound.

A general overview of how the mitochondrial-derived peptide MOTS-c is positioned under Australian regulation as a research compound. General information for researchers, not legal or medical advice.

Research-use-only positioning

MOTS-c is not an approved therapeutic good in Australia. It is supplied strictly for in-vitro laboratory research — not for human or veterinary use, consumption, or therapeutic application.

What this means for a researcher

Researchers should ensure their intended use is genuinely research and complies with the laws and institutional rules that apply to them. A research-use-only label does not by itself exempt any compound from the Therapeutic Goods Act or relevant schedules.

  • Not an approved therapeutic good
  • Supplied for in-vitro research use only
  • Not for human or veterinary use
  • Researchers are responsible for their own compliance

MOTS-c is stocked with a published COA for research use.

View MOTS-c

Frequently asked questions

Is MOTS-c an approved medicine in Australia?
No. It is not an approved therapeutic good; it is supplied strictly for in-vitro laboratory research use only.
What is MOTS-c?
A mitochondrial-derived peptide studied in laboratory research. Argon Peptides supplies it for in-vitro research use only, with a published Certificate of Analysis.

Related reading

Last updated 24 June 2026. This article is general information for researchers, not medical or legal advice.